Management tracks: DBV, Beam, Aeon Biopharma
DBV Technologies S.A. (Euronext:DBV; NASDAQ:DBVT) said Deputy CEO and Principal Financial Officer David Schilansky will leave the company in August to pursue other opportunities. The allergy company is searching for a new CFO but will not fill the deputy CEO position.
Beam Therapeutics (Cambridge, Mass.) hired Christine Bellon as